|
MechanismCYB5R3 modulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Incanthera Oncology Ltd.
0 Patents (Medical) associated with Incanthera Oncology Ltd.
100 Deals associated with Incanthera Oncology Ltd.
100 Translational Medicine associated with Incanthera Oncology Ltd.